Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Net income	$ 2,942	$ 2,097
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:
Amortization of premiums and accretion of discounts on securities, net	520	534
Depreciation and amortization expense	292	305
Deferred income taxes	(2)	164
Stock compensation expense	115	93
Increase in cash value of life insurance	(47)	(47)
Gain on sale of securities	(7)	0
Provision for loan losses	75	351
Proceeds from sales of loans	38,178	23,561
Loans originated for sale	(33,932)	(22,111)
Gain on sale of loans	(636)	(359)
Amortization of tax credit investment	89	96
Unrealized (gain) loss on equity securities	(234)	394
Decrease in accrued interest receivable	333	213
Increase (decrease) in accrued interest payable	(29)	9
Net change in other assets/liabilities	(97)	(768)
Net Cash Provided By Operating Activities	7,560	4,532
CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds from maturities of interest-bearing time deposits	200	245
Purchase of interest-bearing time deposits	0	(245)
Purchase of securities available for sale	(52,436)	(15,390)
Proceeds from maturities of securities available for sale	5,500	9,685
Proceeds from sales of securities available for sale	1,798	0
Principal collected on mortgage-backed obligations	10,699	9,930
Net decrease in loans receivable	17,633	851
Investment in tax credit entity	0	(848)
Proceeds from sale of foreclosed real estate	0	170
Purchase of premises and equipment	(29)	(198)
Net Cash Provided By (Used In) Investing Activities	(16,635)	4,200
CASH FLOWS FROM FINANCING ACTIVITIES
Net increase in deposits	40,061	441
Purchase of treasury stock	40	(0)
Dividends paid	(878)	(811)
Net Cash Provided By (Used In) Financing Activities	39,143	(370)
Net Increase in Cash and Cash Equivalents	30,068	8,362
Cash and cash equivalents at beginning of period	175,888	51,360
Cash and Cash Equivalents at End of Period	$ 205,956	$ 59,722